Short answer
AI agents in pharma regulatory affairs prepare submission content, assess the regulatory impact of change requests and monitor literature and authority publications. Regulatory experts review and sign off every output. kalAIDoCreate builds these agents with validation-ready documentation, strict access control and full audit trails, and operates them under defined change management.
On this page
Regulatory work is document work under scrutiny
Regulatory affairs teams sit between development, quality, manufacturing and the authorities. Their output is documents: dossier sections, variation applications, responses to authority questions, labeling updates, impact assessments for change requests. Each document must be consistent with hundreds of others, traceable to source data and correct in every detail, because an inconsistency can delay an approval or trigger questions from the authority.
Much of the effort is not scientific judgment but assembly and checking: finding the current approved text, comparing versions, collecting the right evidence, tracking which markets are affected by a change. That is exactly the kind of work an accountable AI agent can take on, provided governance is designed in from the start.
Three agent roles in regulatory affairs
Submission preparation assistant. The agent drafts sections from approved source documents, checks cross-references between modules, highlights inconsistencies between labeling texts and source data, and compiles checklists of required documents per procedure. A regulatory manager reviews, edits and approves every draft.
Change control impact analyst. When a change request enters the quality system, the agent identifies affected products, registrations and markets, retrieves the relevant registered details and prepares a draft impact assessment with the likely variation category per market. The responsible expert confirms the classification and decides on the filing strategy.
Literature and intelligence monitor. The agent screens scientific literature and authority publications on a defined schedule, filters items relevant to your portfolio, summarizes them with source links and routes them to the right owner, for example pharmacovigilance or regulatory intelligence. It never closes an item as irrelevant without a documented rule that allows it.
Who decides what
| Step | AI agent | Regulatory expert |
|---|---|---|
| Gather source documents and registered details | owns | reviews on sample |
| Draft document sections and checklists | owns the draft | edits and approves |
| Propose variation category per market | proposes with rationale | decides |
| Screen literature against criteria | owns the screening | assesses relevance and actions |
| Submit to authorities | never | owns |
Governance designed for regulated environments
Because this solution falls under our AI governance and compliance service, documentation is part of the deliverable, not an afterthought. We describe each agent's intended use, inputs, outputs, limits and human review points so your quality unit can decide how it fits into your computerized system validation approach. Prompts, models and rules are versioned, changes run through change control, and every agent action is logged with timestamp, user context and source.
Confidential development data and personal data in safety reports need protection. Textwash Pro anonymizes personal information locally before text is processed, either fully offline or as a privacy layer in front of hosted models. Agents run on the kalAIDoCreate platform with SSO, role-based access and EU data residency, and they connect to document management, regulatory information management and quality systems through scoped interfaces.
Building it with your team
We start with one well-defined use case, for example change control impact pre-assessment for a product family. Our AI Code Engineers build and test the agent against past change requests whose outcome is known, so reviewers can compare agent proposals with real decisions. The agent then runs in a supervised phase before it becomes part of the routine process. For the build itself we draw on our AI agent development practice.
Regulatory professionals also need to understand how these tools behave. neooutput runs hands-on trainings on AI tools and agentic workflows, so your team learns to review agent output critically and to formulate good rules.
What to expect
Experts spend more time on judgment and strategy and less on searching and comparing. Impact assessments start from a structured draft instead of a blank page. Literature monitoring becomes consistent and documented. Inspections and audits benefit from a complete record of what the agent did and who approved it. We agree on measures with you instead of promising generic numbers.
Related solutions
Compliance teams outside pharma use similar patterns, see AI agents for compliance monitoring. Hospital-side documentation is covered in AI agents for healthcare administration.
FAQ
Can AI agents be used in GxP-relevant processes?
They can support them if the intended use, limits and human review points are defined and documented. Your quality unit decides on the validation approach; we provide the documentation and controls it needs.
Does the agent submit anything to authorities?
No. Submissions and official correspondence remain with your regulatory experts. The agent prepares drafts and evidence.
How is confidential data protected?
Access is role-based, data stays in the EU, every action is logged, and personal data can be anonymized locally before any language model sees it.